Carter Gould

Stock Analyst at Cantor Fitzgerald

(3.32)
# 1,023
Out of 4,914 analysts
205
Total ratings
48.33%
Success rate
2.42%
Average return

Stocks Rated by Carter Gould

Amgen
Jun 24, 2025
Reiterates: Neutral
Price Target: $305
Current: $301.29
Upside: +1.23%
Vertex Pharmaceuticals
May 6, 2025
Reiterates: Overweight
Price Target: $535
Current: $460.83
Upside: +16.09%
Bristol-Myers Squibb Company
Apr 23, 2025
Reiterates: Neutral
Price Target: $55
Current: $47.51
Upside: +15.77%
Regeneron Pharmaceuticals
Apr 22, 2025
Assumes: Overweight
Price Target: $695
Current: $558.63
Upside: +24.41%
Pfizer
Apr 22, 2025
Initiates: Neutral
Price Target: $24
Current: $24.31
Upside: -1.28%
Vaxcyte
Apr 22, 2025
Initiates: Overweight
Price Target: n/a
Current: $35.87
Upside: -
Merck & Co.
Apr 22, 2025
Initiates: Neutral
Price Target: $85
Current: $84.06
Upside: +1.12%
Eli Lilly and Company
Apr 22, 2025
Initiates: Overweight
Price Target: $975
Current: $808.11
Upside: +20.65%
Gilead Sciences
Apr 22, 2025
Assumes: Overweight
Price Target: $125
Current: $113.03
Upside: +10.59%
AbbVie
Apr 22, 2025
Initiates: Overweight
Price Target: $210
Current: $188.52
Upside: +11.39%
Maintains: Overweight
Price Target: $160$165
Current: $133.71
Upside: +23.40%
Maintains: Overweight
Price Target: $18$20
Current: $15.40
Upside: +29.87%
Maintains: Equal-Weight
Price Target: $190$180
Current: $129.28
Upside: +39.23%
Initiates: Overweight
Price Target: $100
Current: $81.98
Upside: +21.98%
Maintains: Overweight
Price Target: $10$3
Current: $2.42
Upside: +23.97%
Maintains: Overweight
Price Target: $7$3
Current: $1.55
Upside: +93.55%
Initiates: Overweight
Price Target: $9
Current: $1.15
Upside: +682.61%
Maintains: Overweight
Price Target: $100$95
Current: $36.63
Upside: +159.35%
Maintains: Overweight
Price Target: $25$20
Current: $14.95
Upside: +33.78%
Maintains: Overweight
Price Target: $62$73
Current: $70.59
Upside: +3.41%
Maintains: Overweight
Price Target: $14$12
Current: $1.76
Upside: +581.82%
Maintains: Equal-Weight
Price Target: $2$1.5
Current: $1.98
Upside: -24.24%
Maintains: Equal-Weight
Price Target: $2.5$2.25
Current: $0.49
Upside: +359.18%
Maintains: Equal-Weight
Price Target: $392$380
Current: $236.44
Upside: +60.72%
Downgrades: Neutral
Price Target: $75$82
Current: $70.16
Upside: +16.88%